1. Advocate for multinational studies to enhance the diversity and generalizability of pharmacological studies.

2. Focus on enhancing the quality of ECMO pharmacotherapy, advocating for improved patient outcomes.

3. Contribute to developing and disseminating guidelines for effective pharmacotherapy during ECMO, ensuring alignment with evidence-based recommendations.

4. Develop and promote collaborative ECMO pharmacological research on a global scale.

5. Encourage the integration of pharmacological models in ECMO trials involving therapeutics.